title: Comparative antitumor activity of 5-fluorouracil and its prodrugs in combination with hyperthermia in vitro.
abstract: We investigated the antitumor activities of 5-fluorouracil (5-FU), 5'-deoxy-5-fluorouridine (5'-DFUR), 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(tetrahydro-2-furanyl)-5-fluorouracil (FT-207) in combination with hyperthermia in vitro. The antitumor effect of 5-FU (10(-4) M) was slightly enhanced by combination with hyperthermia (42 degrees C) for 2h, and the effect was determined to be additive. Synergistic enhancement of antitumor activity was obtained by the concurrent use of hyperthermia (42 degrees C, 2h) and 5'-DFUR (10(-4) M) or HCFU (10(-5) M). However, the antitumor effect of FT-207 (10(-4) M) in combination with hyperthermia was comparable that of hyperthermia alone. The synergistic enhancement of antitumor activity was not obtained for all drugs when the cells were preheated at 42 degrees C for 2h. On the other hand, when cells were pretreated with drugs before heat exposure, weak interactions were obtained after 5-FU and 5'-DFUR treatment, and a synergistic interaction was obtained after HCFU treatment. It is speculated that the metabolites of 5'-DFUR and HCFU enhance the cytotoxicity of 5-FU, or might change the threshold concentration for a cytotoxic effect of 5-FU in cancer cells.
authors.affiliation: First Department of Surgery, Okayama University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Shiiki
authors.forename: S
authors.initials: S
authors.lastname: Fuchimoto
authors.forename: H
authors.initials: H
authors.lastname: Iwagaki
authors.forename: Y
authors.initials: Y
authors.lastname: Akazai
authors.forename: N
authors.initials: N
authors.lastname: Matsubara
authors.forename: T
authors.initials: T
authors.lastname: Watanabe
authors.forename: K
authors.initials: K
authors.lastname: Orita
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D005467:Floxuridine / Q000494:pharmacology*; D005472:Fluorouracil / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006358:Hot Temperature; D006801:Humans; D007231:Infant, Newborn; D011355:Prodrugs / Q000494:pharmacology*; D005641:Tegafur / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D011355:Prodrugs; D005467:Floxuridine; D005641:Tegafur; C017367:carmofur; D005472:Fluorouracil; C025034:doxifluridine